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Abstract
Staphylococcus aureus and Streptococcus pneumoniae commonly colonize the upper respiratory tract and can cause invasive disease. Several
studies suggest an inverse relationship between these two bacteria in the nasopharynx. This association is of particular concern as the
introduction of pneumococcal conjugate vaccines (PCVs) that affect pneumococcal nasopharyngeal carriage become widespread. A
cohort of children in rural Gambia were recruited at birth and followed for 1 year, before the introduction of PCV into the routine
immunization program. Nasopharyngeal swabs were taken immediately after birth, every 2 weeks for the ﬁrst 6 months and then every
other month. The presence of S. aureus and S. pneumoniae was determined using conventional microbiologic methods. Prevalence of
S. aureus carriage was 71.6% at birth, decreasing with age to reach a plateau at approximately 20% between 10 to 20 weeks of age.
Carriage with any S. pneumoniae increased during the ﬁrst 10 weeks of life to peak at approximately 90%, mostly of PCV13 serotypes.
Although in the crude analysis S. aureus carriage was inversely associated with carriage of any S. pneumoniae and PCV13 serotypes, after
adjusting by age and season, there was a positive association with any carriage (odds ratio 1.32; 95% conﬁdence interval 1.07–1.64; p
0.009) and no association with carriage of PCV13 serotypes (odds ratio 0.99; 95% conﬁdence interval 0.70–1.41; p 0.973). Among
Gambian infants, S. aureus and S. pneumoniae are not inversely associated in nasopharyngeal carriage after adjustment for age. Further
carriage studies following the introduction of PCV are needed to better understand the relationship between the two bacteria.
New Microbes and New Infections © 2016 The Authors. Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and
Infectious Diseases.
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Introduction
Staphylococcus aureus and Streptococcus pneumoniae are two
common colonizers of the upper respiratory tract that may
cause severe invasive disease [1,2]. S. aureus is the leading cause
of skin and soft tissue infections affecting individuals in the
community and hospitals and also a leading cause of neonatal
sepsis and childhood pneumonia [3,4]. S. pneumoniae is a
frequent cause of pneumonia, meningitis and septicaemia [5].
For both bacteria, asymptomatic colonization (or carriage) of
the nasopharynx is considered a necessary step on the pathway
to disease [6–8].
S. aureus is found most frequently in the anterior nares but
is also commonly found in the oropharynx and nasopharynx,
on the skin and to a lesser extent in the gastrointestinal tract,
perineum and axilla [9]. S. pneumoniae is carried primarily in
the nasopharynx. Carriage of S. pneumoniae is most prevalent
in children and older adults, while S. aureus shows a different
age colonization pattern being highest among neonates
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[10,11] and then relatively constant in older age groups.
Worldwide, approximately 20% to 30% of adults are nasal
carriers of S. aureus [9] but there is wide variation in reports
of S. aureus carriage rates among paediatric and surgical pa-
tient populations in sub-Saharan Africa, ranging from 14% in
Ghana to 47% in South Africa [12]. The prevalence of
S. aureus was highest among white men in one study which
looked at healthy volunteer donors of different ethnic origins
[13].
The introduction of pneumococcal conjugate vaccines
(PCVs) alters the microbial ﬂora in the nasopharynx of vacci-
nated individuals and their contacts. Although the overall
prevalence of pneumococcal carriage has remained constant in
most settings, there has been a substantial decrease of pneu-
mococcal serotypes included in the vaccine, vaccine serotypes
(VT) [14] and an increase in other serotypes not included in the
vaccine, nonvaccine serotypes (NVT) [15,16]. One study found
that S. aureus also increased after the introduction of PCVs [17],
and several studies have reported an inverse association be-
tween asymptomatic carriage of S. pneumoniae and S. aureus
[17–19]. In some instances this inverse association has been
described in relation to speciﬁc pneumococcal serotypes
[20,21].
There are increasing concerns about a potential increase in
S. aureus carriage and disease after the introduction of PCVs
into Africa [22]. In the Gambia, the epidemiology of pneumo-
coccal carriage, before and after PCV introduction, has been
well described [10,23]. However, little is known about the
epidemiology of S. aureus nasopharyngeal carriage. Therefore,
we used available data to study the epidemiology and risk fac-
tors for S. aureus nasopharyngeal carriage in a cohort of
Gambian infants before the introduction of PCV and evaluated
the association with S. pneumoniae carriage.
Methods
Study population
Infants were recruited as part of a large longitudinal carriage
survey that was conducted in a rural area of western Gambia
between 17 December 2003 and 16 June 2005 [10]. We used
samples and data from infants who were part of an ancillary
study that assessed the association between routine vaccination
and bacterial carriage [24]. All infants were vaccinated ac-
cording to the Gambia expanded program of immunization’s
schedule which then offered bacillus Calmette-Guérin, oral
polio, pentavalent (diphtheria, pertussis, tetanus hepatitis B and
Haemophilus inﬂuenzae type b), measles and yellow fever vac-
cines. PCV was introduced into the Gambian expanded pro-
gram of immunization in 2009.
Sample collection
Nasopharyngeal swab samples were taken from infants as soon
as possible after birth, every 2 weeks for the ﬁrst 6 months and
then every other month until their ﬁrst birthday. Swab samples
were collected, transported and stored according to World
Health Organization guidelines [25].
Swabs were collected from the posterior wall of the naso-
pharynx using a calcium alginate swab and immediately placed in
vials containing skim milk–tryptone–glucose–glycerol (STGG)
transport medium. Vials were then transported within 8 hours
of collection to the Medical Research Council (MRC) Unit The
Gambia, Fajara, laboratories and stored at −70°C.
Isolation of bacteria
Samples were tested in batches for S. pneumoniae as part of the
initial study [10]. To isolate S. pneumoniae, 10 μL of a STGG
sample were streaked onto a gentamicin blood agar plate and
incubated for 18 to 24 hours at 35°C in 5% CO2. Pneumococci
were identiﬁed on the basis of colony morphology, optochin
susceptibility and/or bile solubility. Serotyping was done with
capsular and factor typing sera (Statens Serum Institute,
Copenhagen) using the latex agglutination technique [26]. Iso-
lates with equivocal serotype results were conﬁrmed by the
Quellung reaction.
In 2012, the STGG samples were plated again onto agar
plates for the isolation of S. aureus for the ancillary study. To
isolate S. aureus, 50 μL of thawed STGG sample were plated
onto mannitol salt agar plates and incubated for 48 hours at 37°
C in ambient temperature. The plates were examined for yel-
low or white colonies typical of staphylococci and subcultured
onto blood agar plates to obtain pure growth. All suspected
colonies were tested with a catalase test, followed by coagulase
testing when this was positive, using the Remel Staphaurex Plus
kit (OXR30950201; Oxoid) to conﬁrm the identity of S. aureus.
Statistical analysis
We analysed trends in the prevalence of S. aureus and
S. pneumoniae carriage by splitting the sample into 10 groups of
equal size, with the ﬁrst group containing 10% of the samples
taken at the youngest ages, the second group containing those
taken at the next youngest 10% and so on. In addition, we ﬁtted
spline functions to the prevalence data as previously described
[24].
We used logistic regression to model the association be-
tween S. aureus and S. pneumoniae carriage (all serotypes, 13-
valent PCV (PCV13) VT and PCV13-NVT) adjusted for sea-
son and age. Season was included in the model as a binary factor
(dry season from June to October and rainy season from
November to May), and age was included as a restricted cubic
spline. Other risk factors including sex, breast-feeding, upper
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respiratory tract infection (URTI) and ear discharge at the time
of swabbing, antibiotic use and travel out of the study area in
the previous 2 weeks were also examined. Conﬁdence intervals
(CIs) were adjusted for clustering at the village level using
robust standard errors.
We conducted a secondary analysis using conditional logistic
regression to estimate the association between S. aureus and S.
pneumoniae carriage within individuals, thereby eliminating any
confounding attributable to variation between individuals.
Ethical approval
The cohort study was approved by the joint MRC–Gambia
Government (GG) ethics committee and by the ethics com-
mittee of the London School of Hygiene and Tropical Medicine;
the subsequent study that collected additional vaccination data
was also approved by the MRC GG ethics committee. Written
consent was obtained from the parents or guardians of each
infant recruited into the study.
Results
Characteristics of study population
A total of 237 infants were recruited into the original study.
Here, we included all infants from the previous ancillary study
that had data on carriage of S. aureus and S. pneumoniae (i.e.
57.6% of the original cohort); an additional 11 infants were
excluded from that study because their vaccination record was
incomplete [24]. Altogether, 147 infants were included in our
analysis, providing a total of 1873 samples with median of 14
samples per infant (range, 2–17). Overall, 54.4% of these infants
were boys. The median ages at which routine vaccines were
given was 1.9 weeks (interquartile range (IQR) 1.4–2.4) for
bacillus Calmette-Guérin, 26.3 weeks (IQR 22.7–33.3) for the
third dose of the pentavalent vaccine, 43.1 weeks (IQR
40.6–48.1) for measles vaccine and 44.0 weeks (IQR
40.9–48.9) for yellow fever vaccine. The majority of infants
were breast-fed; only on 7/1753 occasions was the infant not
breast-feeding at the time of swabbing.
Prevalence of S. aureus and S. pneumoniae
Of the 1873 samples, 30.9% were positive for S. aureus, 82.0%
positive for S. pneumoniae and 23.2% positive for both bacteria.
The 1535 S. pneumoniae–positive samples yielded 1673 isolates
with a total of 65 serotypes/groups. Among all samples
collected, 51.2% were positive for PCV13-VT and 34.1% were
positive for PCV13-NVT (including 2.9%, n = 49, nontypeable
pneumococci).
Prevalence of S. aureus was highest immediately after birth at
74.5% in the seven samples taken within the ﬁrst 24 hours of
life and decreased to 21.4% by 20 weeks of age. Prevalence of
S. pneumoniae carriage, on the other hand, was low at birth,
increased rapidly with age and reached a plateau after 10 weeks
of age (approximately 90%). In infants older than 20 weeks, the
prevalence of carriage of both bacteria remained constant until
the end of the follow-up at 1 year of age (Fig. 1). The age
pattern of PCV13-VT carriage was similar to that for overall
pneumococcal carriage, but the peak was observed in older
infants at approximately 40 weeks of age. For PCV13-NVT, the
peak of 51% carriage occurred very early (8–9 weeks of age),
and carriage subsequently decreased to about 25% after 34
weeks (Fig. 1).
Risk factors for S. aureus
A crude analysis showed an inverse association between
carriage of S. aureus and S. pneumoniae (inverse association
with any pneumococcal carriage and PCV13-VT carriage)
and also with age (Table 1). After adjusting for age and
season, S. aureus was positively associated with carriage of
any S. pneumoniae (odds ratio (OR) 1.32; 95% CI 1.07–1.64;
p 0.009) but was no longer associated with carriage of
PCV13-VT (OR 0.99; 95% CI 0.70–1.41; p 0.973). In an
analysis using conditional regression, the statistical signiﬁ-
cance of the increased risk of any S. pneumoniae colonization
among S. aureus carriers after adjusting for age and season
was borderline (adjusted OR 1.41; 95% CI 0.99–2.03; p
0.059).
Apart from URTI, which was negatively associated with
carriage, none of the other risk factors tested in the adjusted
analysis was associated with carriage of S. aureus (Table 1).
FIG. 1. Prevalence of Staphylococcus aureus and Streptococcus pneumo-
niae (all serotypes, VT and NVT) by age. Dots indicate prevalence in
each decile of age; lines, predictions from logistic regression where
effect of age on carriage is modelled using spline functions. VT, vaccine
serotype; NVT, nonvaccine serotype.
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Discussion
In this study, we demonstrated that the inverse association
between S. aureus and S. pneumoniae nasopharyngeal carriage
among Gambian infants before the introduction of PCV is
explained by the difference in age pattern of carriage during the
ﬁrst year of life, and we found that the confounding effect of age
masked a potential positive association between S. aureus and S.
pneumoniae.
Several studies have shown an inverse association between
S. aureus and S. pneumoniae in Africa and other regions,
including studies by Bogaert et al. [20] in Dutch children aged 1
to 19 years, and Madhi et al. [27] in South Africa among HIV-
uninfected children about 5 years of age. One of them did
adjust for age. In a randomized controlled trial in the
Netherlands which recruited children aged 1 to 7 years with
recurrent otitis media, S. aureus carriage was higher in children
who received pneumococcal vaccines compared to placebo
[28]. Regev-Yochay et al. [21] found an inverse association that
persisted after adjustment for age among children younger than
40 months old (median, 1.3 years) in Israel. There are differ-
ences between the latter study and ours in that 80% of the
children in the Regev-Yochay et al. study had respiratory tract
infections which could alter the normal ﬂora in the naso-
pharynx [29]. We also swabbed the children more frequently
and included age as a continuous variable in our analysis. In
another Gambian study, an inverse association between overall
pneumococcal carriage and S. aureus carriage also disappeared
in the adjusted analysis [19].
A positive association between S. aureus and S. pneumoniae
has not previously been reported, although Shiri et al. [18]
noted increased S. pneumoniae colonization among individuals
with dual carriage of H. inﬂuenzae and S. aureus. A possible
explanation for this association is that susceptibility to carriage
varies within individuals over time, and this variation affects the
risk of acquiring both S. aureus and S. pneumoniae. The positive
association is not attributable to variation between individuals
in susceptibility to carriage because the association was also
observed in the within-individual analysis.
Our study showed a very high prevalence of S. aureus
nasopharyngeal carriage among Gambian infants, as previously
reported in another setting in the country [30]. Approximately
70% of newborns carried S. aureus; the prevalence decreased to
20% between 10 and 20 weeks of life. A rapid drop in preva-
lence during this ﬁrst year of life has been reported previously
[31], although possibly later in infancy, as shown among PCV-
unvaccinated infants [17]. We found that the age–carriage
trend for VT pneumococci, but not NVT pneumococci, was
similar to the trend for any pneumococcal carriage. This may
explain why van Gils et al. [17] found an inverse association
between S. aureus and VT pneumococci was stronger than that
between S. aureus and NVT pneumococci.
Besides being positively associated with S. pneumoniae, we
found that carriage of S. aureus was negatively associated with
URTI. The reason for this association is unclear, but it might be
TABLE 1. Risk factors for colonization with Staphylococcus aureus and Streptococcus pneumoniae
Risk factor Variable n S. aureus, n (%)
Unadjusted Adjusted
OR (95% CI) p ORa p
S. pneumoniae
Any serotype No 338 144 (42.6) 1 1
Yes 1535 435 (28.3) 0.53 (0.41–0.70) <0.001 1.32 (1.07–1.64) 0.009
PCV13-VT No 915 334 (36.5) 1 1
Yes 958 245 (25.6) 0.60 (0.48–0.75) <0.001 0.99 (0.70–1.41) 0.97
PCV13-NVT No 1235 376 (30.4) 1 1
Yes 638 203 (31.8) 1.07 (0.82–1.39) 0.64 1.13 (0.78–1.63) 0.53
Sex F 865 267 (30.9) 1 1
M 1008 312 (32.0) 1.00 (0.79–1.28) 0.97 0.98 (0.76–1.27) 0.90
Season Rainy 738 176 (23.8) 1 1
Dry 1135 403 (35.5) 1.76 (1.30–2.38) <0.001 1.26 (0.87–1.81) 0.22
Breast-fed Mixed 643 117 (18.2) 1 1
Exclusive 1103 381 (34.5) 2.37 (1.92–2.92) <0.001 1.05 (0.77–1.42) 0.77
URTI No 1673 482 (28.8) 1 1
Yes 79 15 (19.0) 0.58 (0.38–0.88) 0.01 0.58 (0.41–0.84) 0.003
Ear discharge No 1745 495 (28.4) 1 1
Yes 8 2 (25.0) 0.84 (0.20–3.51) 0.82 1.60 (0.36–7.08) 0.54
Antibioticb No 1588 460 (29.0) 1 1
Yes 112 24 (21.4) 0.67 (0.40–1.11) 0.12 0.70 (0.42–1.18) 0.19
Travel outb No 1236 358 (29.0) 1 1
Yes 341 75 (22.0) 0.69 (0.53–0.91) 0.008 0.90 (0.70–1.17) 0.43
Age <12 weeks 644 332 (51.6) 1
12–24 weeks 660 148 (22.4) 0.27 (0.22–0.34) <0.001
>24 weeks 569 99 (17.4) 0.20 (0.15–0.26) <0.001
CI, conﬁdence interval; NVT, nonvaccine serotype; OR, odds ratio; PCV, pneumococcal conjugate vaccine; URTI, upper respiratory tract infection; VT, vaccine serotype.
aAdjusted for season and age as continuous percentiles.
bPrevious 2 weeks.
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due to competitive interaction with other bacteria and possibly
viruses which we did not explore. Carriage of S. aureus was not
associated with breast-feeding, season or antibiotic use. The
absence of an association with breast-feeding is consistent with
the ﬁndings of a large cohort study [31]. On the other hand, the
absence of an association with antibiotic use is not consistent
with previous studies which have shown that recent antibiotic
use lowers S. aureus carriage [32], but it is unsurprising because
antibiotics were rarely used among infants in our study. Sea-
sonality of S. aureus carriage has not been documented,
although the prevalence of S. pneumoniae carriage in children
increases during the dry season [33]. Other factors including
crowding and socioeconomic status may also be important
predictors of bacterial carriage [34], but these data were not
collected in the original study.
S. aureus is primarily carried in the anterior nares; therefore,
carriage of S. aureus might have been more frequently detected
if nasal or oral swabs had been used in addition to nasopha-
ryngeal swabs. In a recent study of Gambian infants, S. aureus
was isolated from 65% of oropharyngeal swabs, but only 36% of
nasopharyngeal swabs [30]. We may therefore have under-
estimated the prevalence of S. aureus. However, we would not
expect this to alter the direction of the association between
S. aureus and S. pneumoniae. The culture for S. aureus was done
several years after initial sample storage. Hare et al. [35] have
shown that other respiratory pathogens remain viable when
cultured from original swabs stored in STGG at −70°C for up
to 12 years. S. aureus, though not one of the bacteria in their
study, is a very robust organism and there is no reason to
believe it would behave differently.
In assessing the relationship between S. aureus and S. pneu-
moniae, age should be considered as an important confounder,
at least among infants. After controlling for the effect of age,
our study found a positive association between these two
pathogens in the nasopharynx of infants, which suggests that
S. aureus will not increase in prevalence after the introduction
of PCV. However, further surveys of bacterial carriage after
introduction of PCVs in the Gambia are required to conﬁrm
this prediction.
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